EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Multizentrische Studie

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes

Trevor W Reichman, James F Markmann, Jon Odorico, Piotr Witkowski iD, John J Fung, Martin Wijkstrom, Fouad Kandeel, Eelco J P de Koning, Anne L Peters, Chantal Mathieu, Leslie S Kean, Bote G Bruinsma und 9 weitere

New England Journal of Medicine · 04.09.2025 · 393 (9) · 858-868

DOI: 10.1056/nejmoa2506549 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 04.09.2025. Verfasst von Trevor W Reichman und 20 weiteren Autor:innen. Beteiligte Einrichtung: Toronto General Hospital, University Health Network, University of Toronto, Toronto. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia, Islets of Langerhans, Islets of Langerhans Transplantation. Die Arbeit wurde bisher 206-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Vertex Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaIslets of LangerhansIslets of Langerhans TransplantationAdultFemaleHumansMaleMiddle AgedYoung AdultBlood GlucoseC-PeptideCell DifferentiationFollow-Up StudiesGlycated HemoglobinHypoglycemic AgentsImmunosuppressive AgentsInfusions, IntravenousInsulinTransplantation, Homologous

Substanzen

Blood GlucoseC-PeptideGlycated HemoglobinHypoglycemic AgentsImmunosuppressive AgentsInsulin

Autor:innen und Institutionen

  • Toronto General Hospital, University Health Network, University of Toronto, Toronto.
  • University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • University of Wisconsin, Madison.
  • University of Chicago, Chicago.
  • University of Pittsburgh Medical Center, Pittsburgh.
  • City of Hope National Medical Center, Duarte, CA.

ORCID-Profile: Piotr Witkowski, Michael R Rickels

Förderung

  • Vertex Pharmaceuticals

Zitieren

APA

Reichman, T. W., Markmann, J. F., Odorico, J., Witkowski, P., Fung, J. J., Wijkstrom, M., Kandeel, F., de Koning, E. J. P., Peters, A. L., Mathieu, C., Kean, L. S., Bruinsma, B. G., Wang, C., Mascia, M., Sanna, B., Marigowda, G., Pagliuca, F., Melton, D., Ricordi, C., …, & VX-880-101 FORWARD Study Group (2025). Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes. New England Journal of Medicine, 393(9), 858-868. https://doi.org/10.1056/nejmoa2506549

Vancouver

Reichman TW, Markmann JF, Odorico J, Witkowski P, Fung JJ, Wijkstrom M, et al. Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes. New England Journal of Medicine. 2025;393(9):858-868. doi:10.1056/nejmoa2506549

BibTeX
@article{Reichman2025,
  author = {Reichman, Trevor W and Markmann, James F and Odorico, Jon and Witkowski, Piotr and Fung, John J and Wijkstrom, Martin and Kandeel, Fouad and de Koning, Eelco J P and Peters, Anne L and Mathieu, Chantal and Kean, Leslie S and Bruinsma, Bote G and Wang, Chenkun and Mascia, Molly and Sanna, Bastiano and Marigowda, Gautham and Pagliuca, Felicia and Melton, Doug and Ricordi, Camillo and Rickels, Michael R and VX-880-101 FORWARD Study Group, VX-880-101 FORWARD Study Group},
  title = {Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {9},
  pages = {858--868},
  doi = {10.1056/nejmoa2506549}
}
Kostenlos starten →